Ben Van Camp

3.7k total citations
53 papers, 2.4k citations indexed

About

Ben Van Camp is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Ben Van Camp has authored 53 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 26 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Ben Van Camp's work include Multiple Myeloma Research and Treatments (42 papers), Cell Adhesion Molecules Research (12 papers) and Chemokine receptors and signaling (10 papers). Ben Van Camp is often cited by papers focused on Multiple Myeloma Research and Treatments (42 papers), Cell Adhesion Molecules Research (12 papers) and Chemokine receptors and signaling (10 papers). Ben Van Camp collaborates with scholars based in Belgium, United Kingdom and United States. Ben Van Camp's co-authors include Karin Vanderkerken, Ivan Van Riet, Kewal Asosingh, Peter I. Croucher, Eline Menu, Hendrik De Raeve, Els Van Valckenborgh, C M Shipman, Isabelle Vande Broek and Song Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Ben Van Camp

52 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Van Camp Belgium 28 1.3k 1.2k 1.2k 351 265 53 2.4k
Hendrik De Raeve Belgium 34 1.3k 1.0× 1.4k 1.2× 1.1k 1.0× 375 1.1× 366 1.4× 91 2.9k
Riitta Alitalo Finland 25 594 0.5× 1.5k 1.3× 885 0.8× 450 1.3× 331 1.2× 52 2.5k
Sabrina Bonomini Italy 23 949 0.7× 893 0.8× 1.0k 0.9× 175 0.5× 205 0.8× 49 2.0k
Els Van Valckenborgh Belgium 36 1.3k 1.0× 1.8k 1.5× 1.1k 0.9× 677 1.9× 610 2.3× 77 2.9k
Ralf Bieker Germany 20 727 0.6× 920 0.8× 465 0.4× 289 0.8× 157 0.6× 30 1.6k
Matthias Kotzsch Germany 30 607 0.5× 1.1k 0.9× 486 0.4× 530 1.5× 227 0.9× 75 2.3k
Diana Griffith United States 16 1.1k 0.9× 852 0.7× 742 0.6× 234 0.7× 471 1.8× 22 5.1k
Nerbil Kilic Germany 19 366 0.3× 1.7k 1.4× 705 0.6× 463 1.3× 252 1.0× 30 2.6k
Antoinette Hatzfeld France 27 814 0.6× 1.1k 0.9× 446 0.4× 207 0.6× 551 2.1× 74 2.2k
Mark B. Meads United States 12 441 0.3× 771 0.7× 753 0.6× 307 0.9× 307 1.2× 36 1.6k

Countries citing papers authored by Ben Van Camp

Since Specialization
Citations

This map shows the geographic impact of Ben Van Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Van Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Van Camp more than expected).

Fields of papers citing papers by Ben Van Camp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Van Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Van Camp. The network helps show where Ben Van Camp may publish in the future.

Co-authorship network of co-authors of Ben Van Camp

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Van Camp. A scholar is included among the top collaborators of Ben Van Camp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Van Camp. Ben Van Camp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jinsong, Els Van Valckenborgh, Dehui Xu, et al.. (2013). Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro. Molecular Cancer Therapeutics. 12(9). 1763–1773. 49 indexed citations
2.
Xu, Song, Kim De Veirman, Holly Evans, et al.. (2013). Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacologica Sinica. 34(5). 699–709. 50 indexed citations
3.
Lemaire, Miguel, Prasoon Agarwal, Eline Menu, et al.. (2012). The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin. Clinical Cancer Research. 18(8). 2230–2239. 13 indexed citations
4.
Xu, Song, Ann De Becker, Hendrik De Raeve, et al.. (2012). In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo. Biochemical and Biophysical Research Communications. 424(3). 391–397. 13 indexed citations
5.
Menu, Eline, Els Van Valckenborgh, Ben Van Camp, & Karin Vanderkerken. (2009). The role of the insulin-like growth factor 1 receptor axis in multiple myeloma. Archives of Physiology and Biochemistry. 115(2). 49–57. 32 indexed citations
6.
Caers, Jo, Isabelle Vande Broek, Hendrik De Raeve, et al.. (2008). Multiple myeloma – an update on diagnosis and treatment. European Journal Of Haematology. 81(5). 329–343. 50 indexed citations
7.
Menu, Eline, Helena Jernberg‐Wiklund, Hendrik De Raeve, et al.. (2007). Targeting the IGF‐1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival. International Journal of Cancer. 121(8). 1857–1861. 54 indexed citations
8.
Edwards, Claire M., Anke J. Roelofs, Andrew Chantry, et al.. (2007). Apomine™, an inhibitor of HMG‐CoA‐reductase, promotes apoptosis of myeloma cellsin vitroand is associated with a modulation of myelomain vivo. International Journal of Cancer. 120(8). 1657–1663. 17 indexed citations
9.
Menu, Eline, Evy De Leenheer, Hendrik De Raeve, et al.. (2006). Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clinical & Experimental Metastasis. 23(5-6). 291–300. 90 indexed citations
10.
Caers, Jo, Kewal Asosingh, Ben Van Camp, Ivan Van Riet, & Karin Vanderkerken. (2004). Of mice and men, disease models of multiple myeloma.. Open Repository and Bibliography (University of Liège). 1 indexed citations
11.
Asosingh, Kewal, et al.. (2004). Part of the multiple myeloma-associated microvessels is functionally connected to the systemic circulation: a study in the murine 5T33MM model. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 445(4). 389–395. 4 indexed citations
12.
Menu, Eline, Kewal Asosingh, Ivan Van Riet, et al.. (2004). Myeloma cells (5TMM) and their interactions with the marrow microenvironment. Blood Cells Molecules and Diseases. 33(2). 111–119. 26 indexed citations
13.
Valckenborgh, Els Van, Peter I. Croucher, Hendrik De Raeve, et al.. (2004). Multifunctional Role of Matrix Metalloproteinases in Multiple Myeloma. American Journal Of Pathology. 165(3). 869–878. 42 indexed citations
14.
Croucher, Peter I., C M Shipman, Ben Van Camp, & Karin Vanderkerken. (2003). Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease. Cancer. 97(S3). 818–824. 27 indexed citations
15.
Asosingh, Kewal, et al.. (2003). Selective in vivo growth of lymphocyte function- associated antigen-1–positive murine myeloma cells. Experimental Hematology. 31(1). 48–55. 13 indexed citations
16.
Vanderkerken, Karin, Isabelle Vande Broek, Décio L. Eizirik, et al.. (2002). Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells. Clinical & Experimental Metastasis. 19(1). 87–90. 45 indexed citations
17.
Riet, Ivan Van, Karin Vanderkerken, Catherine De Greef, & Ben Van Camp. (1998). Homing behaviour of the malignant cell clone in multiple myeloma. Medical Oncology. 15(3). 154–164. 25 indexed citations
18.
Bâkkus, Marleen, Ivan Van Riet, Ben Van Camp, & Kris Thielemans. (1994). Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell. British Journal of Haematology. 87(1). 68–74. 121 indexed citations
19.
Riet, Ivan Van, et al.. (1994). Production of fibronectin and adherence to fibronectin by human myeloma cell lines. British Journal of Haematology. 87(2). 258–265. 24 indexed citations
20.
Riet, Ivan Van & Ben Van Camp. (1993). The Involvement of Adhesion Molecules in the Biology of Multiple Myeloma. Leukemia & lymphoma. 9(6). 441–452. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hendrik De Raeve Breakdown of academic impact, for papers by Riitta Alitalo Breakdown of academic impact, for papers by Sabrina Bonomini Breakdown of academic impact, for papers by Els Van Valckenborgh Breakdown of academic impact, for papers by Ralf Bieker Breakdown of academic impact, for papers by Matthias Kotzsch Breakdown of academic impact, for papers by Diana Griffith Breakdown of academic impact, for papers by Nerbil Kilic Breakdown of academic impact, for papers by Antoinette Hatzfeld Breakdown of academic impact, for papers by Mark B. Meads
Rankless by CCL
2026